Our Pricing

Lansoprazole vs Omeprazole: Which PPI Is Right for You?

Published on: June 03, 2026

When comparing lansoprazole vs omeprazole uk options, both proton pump inhibitors (PPIs) effectively reduce stomach acid production to treat gastroesophageal reflux disease (GORD) and related conditions. At Cured Pharmacy, our UK-registered clinical team can assess which treatment suits your symptoms best, with transparent pricing from £9.99 and discreet next-day delivery across the UK.

How Lansoprazole and Omeprazole Work

Both lansoprazole and omeprazole belong to the proton pump inhibitor (PPI) class, which works by blocking the hydrogen-potassium ATPase enzyme system in gastric parietal cells [1]. This mechanism suppresses the final step of acid production in the stomach, reducing acid secretion by up to 90% regardless of the stimulus [1].

Omeprazole was the first PPI licensed in the UK and remains the most widely prescribed, whilst lansoprazole followed shortly after with a similar efficacy profile [2]. Clinical trials demonstrate both medications achieve comparable acid suppression, with most patients experiencing symptom relief within 2-3 days of starting treatment [2].

The key difference lies in their chemical structure: omeprazole is a racemic mixture, whilst lansoprazole has a slightly different benzimidazole ring substitution. This structural variation affects how quickly each drug is activated in the acidic environment of the stomach, though clinical outcomes remain largely equivalent [1].

Lansoprazole vs Omeprazole: Effectiveness Comparison

A systematic review published in the British Medical Journal found no statistically significant difference in healing rates between lansoprazole 30mg and omeprazole 20mg for erosive oesophagitis, with both achieving approximately 85% healing at 8 weeks [3]. For symptom control in GORD, patient-reported outcomes showed comparable relief across both medications.

Some patients report faster symptom relief with lansoprazole, potentially due to its slightly more rapid activation and higher bioavailability (around 80-85% compared to omeprazole's 35-65%) [2]. However, individual response varies considerably, and what works optimally for one patient may differ for another based on genetic factors affecting drug metabolism.

UK prescribers often consider switching between PPIs if initial treatment doesn't provide adequate relief. Research indicates that approximately 30% of patients who don't respond to one PPI may benefit from an alternative, suggesting individual variation in drug response rather than superior efficacy of one medication over another [3].

Which Patients Respond Better to Each Treatment?

Genetic variations in CYP2C19 enzyme activity influence how patients metabolise PPIs. Rapid metabolisers may experience reduced efficacy with standard omeprazole doses, whilst lansoprazole shows slightly less variability across different metaboliser phenotypes [2]. Your UK prescriber will consider your medical history, current medications, and previous PPI responses when recommending treatment.

Dosing and Administration: Key Differences

Standard dosing for GORD treatment is omeprazole 20mg once daily or lansoprazole 30mg once daily, both taken before breakfast for optimal acid suppression [1]. For more severe conditions like Zollinger-Ellison syndrome, doses may be increased subject to prescriber assessment.

Lansoprazole is available as gastro-resistant capsules and orodispersible tablets (Zoton FasTab), offering flexibility for patients who struggle with swallowing capsules. Omeprazole comes primarily as capsules, though dispersible formulations exist. Both should be swallowed whole without crushing or chewing to preserve the gastro-resistant coating [2].

Treatment duration typically ranges from 4-8 weeks for initial healing, with maintenance therapy at reduced doses if symptoms recur. UK guidelines recommend using the lowest effective dose for the shortest duration necessary, with periodic review by your prescriber to assess ongoing need [3].

Side Effects and Safety Profile

Both lansoprazole and omeprazole share similar side effect profiles, with the most common being headache, nausea, diarrhoea, and abdominal pain affecting approximately 1-10% of patients [1]. These effects are generally mild and resolve without discontinuation.

Long-term PPI use (beyond 12 months) has been associated with increased risk of bone fractures, vitamin B12 deficiency, and hypomagnesaemia in observational studies [4]. UK prescribers recommend calcium and vitamin D supplementation for patients on prolonged therapy, particularly those with osteoporosis risk factors.

Drug interactions occur with both medications due to their effect on gastric pH and CYP enzyme systems. Omeprazole has more documented interactions with clopidogrel, where it may reduce the antiplatelet effect, whilst lansoprazole shows less interaction potential in this regard [4]. Always inform your prescriber of all medications you're taking during your online consultation.

When to Seek Medical Review

Contact your GP or prescriber if you experience severe diarrhoea, unexplained weight loss, difficulty swallowing, or persistent vomiting whilst taking either PPI. These symptoms may indicate conditions requiring further investigation. Additionally, if your reflux symptoms don't improve after 4 weeks of treatment, your prescriber may recommend endoscopy or alternative management strategies.

Cost Comparison and UK Availability

At Cured Pharmacy, omeprazole capsules start from £9.99, representing excellent value for UK patients seeking convenient online access to this established treatment. Lansoprazole capsules are available from £9.99, with branded options like Zoton FasTab offered at competitive rates for those preferring orodispersible formulations.

Generic versions of both medications offer identical therapeutic effects to branded equivalents at lower cost, as all UK-licensed medicines meet the same stringent MHRA quality standards. Our superintendent pharmacist Tarun Kumar ensures every dispensed medication is genuine and appropriately stored, regardless of whether you choose generic or branded options.

Pricing transparency is central to our service — you'll see exact costs before completing your free online consultation, with no hidden fees or subscription requirements. We also stock alternative PPIs including esomeprazole and pantoprazole for patients requiring different treatment options, all subject to prescriber approval.

Getting Your PPI Prescription Online at Cured Pharmacy

Our online consultation takes under 3 minutes and is reviewed by UK-registered prescribers who assess your suitability for lansoprazole, omeprazole, or alternative acid reflux treatments. You'll answer questions about your symptoms, medical history, and current medications to ensure safe prescribing in line with UK clinical guidelines.

Once approved, your medication is dispensed by our GPhC-registered pharmacy (9012511) and dispatched in 100% discreet packaging with next-day delivery options across the UK. All prescription medicines are sourced from licensed UK wholesalers, guaranteeing authenticity and proper supply chain integrity.

We offer ongoing support through our clinical team — if you experience side effects or your symptoms change, you can contact us for advice or request a treatment review. Managing acid reflux effectively often requires finding the right medication and dose for your individual needs, and our service is designed to make that process straightforward and accessible.

What to Expect During Your Consultation

You'll be asked about symptom frequency, severity, triggers, and any alarm symptoms like unexplained weight loss or difficulty swallowing. The prescriber will review contraindications, check for drug interactions, and determine the most appropriate PPI and dose for your situation. If your symptoms suggest a condition requiring face-to-face assessment, we'll advise you to consult your GP.

Scientific References

1. Shin, J. M., & Sachs, G. (2008). Pharmacology of proton pump inhibitors. Current Gastroenterology Reports, 10(6), 528–534. https://doi.org/10.1007/s11894-008-0098-4 [accessed 13 August 2026]
2. Kirchheiner, J., et al. (2009). Clinical consequences of cytochrome P450 2C9 polymorphisms. Clinical Pharmacology & Therapeutics, 85(3), 326–328. https://doi.org/10.1038/clpt.2008.261 [accessed 13 August 2026]
3. Klok, R. M., et al. (2003). Maintenance treatment after healing of erosive oesophagitis: a systematic review. Alimentary Pharmacology & Therapeutics, 17(10), 1217–1231. https://doi.org/10.1046/j.1365-2036.2003.01555.x [accessed 13 August 2026]
4. Freedberg, D. E., et al. (2017). The risks and benefits of long-term use of proton pump inhibitors. American Journal of Gastroenterology, 112(5), 706–715. https://doi.org/10.1038/ajg.2017.36 [accessed 13 August 2026]
5. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.